JUL 03, 2019 10:49 AM PDT

Treating Psychosis by Targeting a Genetic Mutation

WRITTEN BY: Carmen Leitch

It may one day be possible to treat psychiatric disorders with therapies that target genetic mutations. New research has shown that in some psychosis patients, tailoring a treatment to a gene dysfunction can relieve symptoms of their disease. The work also demonstrated how some gene defects are linked to the etiology of psychosis. The findings have been reported in Biological Psychiatry.

Image credit: Pixabay

There are not many known genetic mutations that have a major influence on the risk of psychiatric disorders, but some have been found. Researchers led by Deborah L. Levy, Ph.D. of McLean Hospital, which is an affiliate of Harvard Medical School, recently found a copy-number variant (CNV) mutation in two of four patients. The two individuals each carried two extra copies of the glycine decarboxylase gene (GLDC), which catabolizes glycine.

The researchers thought that the CNV mutation could cause a drop in glycine levels in the brain. In schizophrenia, glutamatergic functioning is disrupted, which may be influenced by this mutation.

The scientists assessed molecules that could restore glycine or glutamate function, and found that they helped relieve symptoms of psychosis in the patients carrying the mutation. They experienced a reduction in mood symptoms, less social withdrawal, and enhanced emotional engagement. While a cohort of only two patients is tiny, it shows that there is room for improvement in the treatment of psychiatric diseases.

"The compelling aspect is that this CNV can be linked to pathophysiology, and, as the new study shows, to treatment," noted Dr. Levy. "This approach contrasts with the standard clinical practice of treating individuals on the basis of clinical symptoms or diagnosis independent of specific genetic variants."

"It is important to note that the two subjects studied here bore little clinical resemblance, with distinctly different symptom burdens, and highly dissimilar courses of illness," explained the study first author J. Alexander Bodkin, MD of McLean Hospital. The treatment may, therefore, have been effectively improving an impaired biological mechanism, which was not dependent on a very specific clinical diagnosis.

"Most studies of rare structural variants will have very small sample sizes, complicating the usual approach to statistical analysis. Nevertheless, because the effects of a targeted treatment can be large, it is important to prioritize opportunities to study even small groups of patients who may benefit," added author Charity J. Morgan of the University of Alabama.

"The substances that they administered, glycine and D-cycloserine, do not produce noticeable behavioral effects in healthy people or in patients with psychotic disorders. However, because these substances replaced a deficient cofactor involved in neural communication in these particular individuals, their administration alleviated mood and psychosis symptoms," said John Krystal, MD, the Editor of Biological Psychiatry. As in these cases, we expect psychiatry to develop more instances where specific treatments can be developed to meet the needs of particular groups of patients."

Learn more about copy number variation from the video.


Sources: AAAS/Eurekalert! via Elsevier, Biological Psychiatry

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 14, 2020
Cancer
MiR-107 and Its Role in Radiosensitivity in Prostate Cancer
SEP 14, 2020
MiR-107 and Its Role in Radiosensitivity in Prostate Cancer
It is often unknown whether a patient will respond to a treatment until it is in full swing. New research is attempting ...
SEP 13, 2020
Cell & Molecular Biology
RNA Found on the Surface of Human Cells
SEP 13, 2020
RNA Found on the Surface of Human Cells
The surface of a cell carries many features to help it carry out its functions, communicate with other cells, gather inf ...
OCT 03, 2020
Genetics & Genomics
Genetic Changes Can Influence Cocaine Addiction
OCT 03, 2020
Genetic Changes Can Influence Cocaine Addiction
There is no treatment for cocaine addiction, which affects millions of people around the world and has a high relapse ra ...
OCT 22, 2020
Cell & Molecular Biology
How a Gene Variant Raises the Risk of Multiple Sclerosis
OCT 22, 2020
How a Gene Variant Raises the Risk of Multiple Sclerosis
Now that sequencing the whole human genome is easier, faster, and cheaper than it used to be, scientists have been able ...
OCT 26, 2020
Genetics & Genomics
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
OCT 26, 2020
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
People that eat a 'paleo' diet operate under the idea that we should be eating more like our ancestors, and that metabol ...
NOV 10, 2020
Microbiology
New Species of Rocky Mountain Spotted Fever-Causing Bacteria is IDed
NOV 10, 2020
New Species of Rocky Mountain Spotted Fever-Causing Bacteria is IDed
Ticks transmit the bacterial pathogen that causes Rocky Mountain Spotted Fever (RMSF).
Loading Comments...